UK markets close in 4 hours 17 minutes

Travere Therapeutics, Inc. (TVTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.75+0.20 (+3.05%)
At close: 04:00PM EDT
6.75 0.00 (0.00%)
After hours: 06:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
155,724
145,238
109,460
131,836
198,321
Cost of revenue
8,809
11,450
4,420
3,818
6,126
Gross profit
146,915
133,788
105,040
128,018
192,195
Operating expenses
Research development
301,453
244,990
227,333
201,159
131,773
Selling general and administrative
263,815
265,542
197,520
126,284
135,799
Total operating expenses
565,268
510,532
424,853
327,443
267,572
Operating income or loss
-418,353
-376,744
-319,813
-199,425
-75,377
Interest expense
11,284
11,334
11,014
19,682
19,050
Total other income/expenses net
-9,908
-9,800
-6,604
231
-99,366
Income before tax
-415,391
-376,110
-331,155
-216,883
-188,790
Income tax expense
336
223
313
409
-19,359
Income from continuing operations
-415,727
-376,333
-331,468
-217,292
-169,431
Net income
-161,129
-111,399
-278,482
-180,091
-169,431
Net income available to common shareholders
-161,129
-111,399
-278,482
-180,091
-169,431
Basic EPS
-1.32
-1.50
-4.37
-3.01
-3.56
Diluted EPS
-1.32
-1.50
-4.37
-3.01
-3.56
Basic average shares
71,198
74,267
63,759
59,832
47,540
Diluted average shares
71,198
74,267
63,759
59,832
47,540